1. COST – Working Group 6 – Toxicology – project CA23131 – ISO compatible, efficient and reproducible protocols/equipment for mICro-nanoPLASTIC detection through machine-learning (ICPLASTIC), 2024-2028; Project Team Member – Prof. Ewa Florek, Ph.D., D.Sc., Prof. Małgorzata Kujawska, Ph.D., D.Sc., Marta Szukalska, Ph.D.
  2. New graphene-based approach targeting the prion-like propagation of α-synuclein in Parkinson’s disease – project NCN. Consortium – Poznan University of Medical Sciences, The Maj Institute of Pharmacology Polish Academy of Sciences, 2021/42/E/NZ7/00246, 2022-2027; Principal Investigator – Prof. Małgorzata Kujawska, Ph.D., D.Sc.
  3. Application of biomimetic coatings in advanced liver cancer therapy – project NCN. Consortium – Poznan University of Medical Sciences, Centrum NanoBioMed UAM, UMO 2018/31/D/ST8/02434, 2018-2024; Project Partner – Prof. Ewa Florek, Ph.D., D.Sc.
  4. Development of modern nanomaterials for triple therapy of hepatocellular carcinoma – project NCN. Consortium – Poznan University of Medical Sciences, Centrum NanoBioMed UAM. UMO-2018/31/B/ST8/02460, 2018-2025; Project Partner – Prof. Ewa Florek, Ph.D., D.Sc.
  5. In vivo study of the biodistribution of polydopamine-based nanoparticles – project NCN. Poznan University of Medical Sciences, 2019/03/X/NZ7/01940, 2019-2021; Project Manager Marta Szukalska, Ph.D.